Human Microbiome Market Size

  • Report ID: 4062
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Human Microbiome Market Size

Human Microbiome Market size was over USD 445.92 million in 2024 and is projected to cross USD 11.73 billion by the end of 2037, witnessing more than 32.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of human microbiome is estimated at USD 561.5 million. The rising cases of lifestyle-related diseases such as diabetes and the increasing investment in biological drug development across the globe are expected to propel market growth. It is found that dysbiosis, or abnormalities in the microbiome, can lead to the development of several lifestyle disorders.

The rise in research activities about the impact of the microbiome on health and the development of microbiome-based goods and services is predicted to create the potential for market expansion over the estimated period. Additionally, increasing technological advancements are further believed to fuel the growth of the human microbiome market. For instance, it is now simpler and less expensive to investigate the microbiome owing to developments in DNA sequencing technology.


Human Microbiome Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4062
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of human microbiome is estimated at USD 561.5 million.

The human microbiome market size was over USD 445.92 million in 2024 and is projected to cross USD 11.73 billion by the end of 2037, witnessing more than 32.2% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of the human microbiome in health and disease and increasing research on its major impact on human physiology, metabolic and immune functions will boost the market growth.

North America is poised to account for the largest share of 35% by 2037, driven by rising pet adoption in the region.

The major players in the market include Seres Therapeutics, Inc., Evelo Biosciences, Inc., Synlogic, Inc., Second Genome Inc., Synthetic Biologics, Inc., YSOPIA Bioscience, 4D Pharma plc, DuPont de Nemours, Inc., BiomX Inc., Sun Genomics, Inc., Viome Life Sciences, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample